Chia‐Yu Chu

13.0k citations
212 papers · 8.0k · 7 hit papers · h-index 41

Impact in

  • Dermatology top 0.05%
    • Dermatology and Skin Diseases
    • Contact Dermatitis and Allergies
  • Pharmacology top 0.1%
    • Drug-Induced Adverse Reactions

Papers in

    • Dermatology and Skin Diseases 55
    • Contact Dermatitis and Allergies 15
    • Urticaria and Related Conditions 34
    • Eosinophilic Disorders and Syndromes 13

Chia‐Yu Chu

192 papers receiving 7.8k citations

Chia‐Yu Chu's Hit Papers

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis 2023 · 180 citations
1800+9+18Years since publication250500750

Peers

Chia‐Yu Chu
Comparison fields: 5 of 144
  • Dermatology 2.0k
  • Pharmacology 2.3k
  • Immunology and Allergy 706
  • Rheumatology 1.7k
  • Pathology and Forensic Medicine 903
Replace Yuan-Tsong Chen with:
Yuan-Tsong Chen United States
Robert Gniadecki Denmark
Carlos E. Bueso‐Ramos United States
Ernst Gleichmann Germany
Ulrich Beuers Netherlands
Peter Petzelbauer Austria
Bernard Weill France
Joaquín J. Jiménez United States
María Jesús Fernández‐Aceñero Spain
Qianjin Lu China
Chia‐Yu Chu relative to Yuan-Tsong Chen United States Yuan-Tsong Chen's profile →
Citations per field
00.5×12.0×
Yuan-Tsong Chen · 1×
Citations per year

Countries citing papers authored by Chia‐Yu Chu

Since Specialization
Citations

This map shows the geographic impact of Chia‐Yu Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Yu Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Yu Chu more than expected).

Fields of papers citing papers by Chia‐Yu Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Yu Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Yu Chu. The network helps show where Chia‐Yu Chu may publish in the future.

Co-authors

The 25 scholars most cited alongside Chia‐Yu Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chia‐Yu Chu Line = papers co-authored together Chia‐Yu Chu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.

#Work
1
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hit paper breakdown →
2005944
2
The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro
Hit paper breakdown →
1999806
3
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study
Hit paper breakdown →
2013628
4
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
Hit paper breakdown →
2021369
5
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Hit paper breakdown →
2021306
6 2008298
7 2010242
8 2010222
9
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Hit paper breakdown →
2023180
10 2017175
11 2010167
12 2012139
13 2007135
14
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
Hit paper breakdown →
2022131
15 2011126
16 2008112
17 2004110
18 201490
19 200880
20 201379

About Chia‐Yu Chu

Chia‐Yu Chu is a scholar working on Dermatology, Rheumatology, Oncology, Pathology and Forensic Medicine and Pharmacology, having authored 212 papers that have together received 8.0k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (55 papers), Urticaria and Related Conditions (34 papers), Autoimmune Bullous Skin Diseases (28 papers), Drug-Induced Adverse Reactions (28 papers), Allergic Rhinitis and Sensitization (21 papers), Contact Dermatitis and Allergies (15 papers), Eosinophilic Disorders and Syndromes (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). The work is most often cited by research in Dermatology (2.0k citations), Pharmacology (2.3k citations), Immunology and Allergy (706 citations), Rheumatology (1.7k citations) and Pathology and Forensic Medicine (903 citations). Chia‐Yu Chu has collaborated with scholars based in Taiwan, United States and Germany. Frequent co-authors include Yung‐Tsu Cho, Hsien‐Ching Chiu, J. Wade Harper, Jeffrey Winston, Min‐Liang Kuo, Stephen J. Elledge, Peggy Beer‐Romero, Peter R. Strack, Yi‐Chun Chen and Shiou‐Hwa Jee. Their work appears in journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology, Acta Dermato Venereologica, Dermatology and Therapy and Journal of the European Academy of Dermatology and Venereology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact